4.0 Article

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Journal

ARTHRITIS AND RHEUMATISM
Volume 65, Issue 1, Pages 1-11

Publisher

WILEY-BLACKWELL
DOI: 10.1002/art.37715

Keywords

-

Categories

Funding

  1. Roche
  2. GlaxoSmithKline
  3. Actelion Pharma
  4. Genentech
  5. Sanofi-Aventis
  6. Human Genome Sciences
  7. Nordic Pharma
  8. ChemoCentryx
  9. Novartis Turkey
  10. Swedish Orphan Biovitrum
  11. Baxter Innovations Vienna
  12. Proximagen
  13. Chief Scientist Office [CAF/08/08] Funding Source: researchfish

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available